Literature DB >> 26153068

Acetaldehyde sequestration by D-penicillamine prevents ethanol relapse-like drinking in rats: evidence from an operant self-administration paradigm.

Lucía Martí-Prats1, Teodoro Zornoza, José Antonio López-Moreno, Luis Granero, Ana Polache.   

Abstract

RATIONALE: Previous experiments in our laboratory have shown that D-penicillamine (DP) (acetaldehyde sequestering agent) is able to block the increase in ethanol consumption observed after a period of imposed deprivation (the so-called alcohol deprivation effect (ADE)), using a non-operant paradigm in Wistar rats.
OBJECTIVES: This study is aimed at investigating the robustness and reproducibility of our previous data using an operant paradigm, which is considered to be a valid and reliable model of human drug consumption, and the ADE, probably the most often used measure of ethanol relapse-drinking behaviour in rats.
METHODS: Male Wistar rats with a limited (30-min sessions), intermittent and extended background of ethanol operant self-administration were used. In order to evaluate the efficacy of several DP doses (6.25, 12.5 and 25 mg/kg i.p.) in preventing alcohol relapse, we set up a protocol based on the ADE. In a separate experiment, the effect of DP on spontaneous motor activity of rats was also tested.
RESULTS: A significant ADE was observed in animals treated with saline. DP treatment blocked the increase in ethanol responses following the imposed abstinence period. The higher dose suppressed the ADE and provoked a significant reduction in ethanol consumption with respect to the baseline conditions. Basal motor activity was not altered after DP treatment.
CONCLUSION: Our positive results with DP, using two different paradigms that evaluate relapse of ethanol drinking, will help to increase the positive predictive value of pre-clinical experiments and offer a solid base to inspire human studies with DP.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26153068     DOI: 10.1007/s00213-015-4011-1

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  37 in total

1.  The Orexin-1 Receptor Antagonist SB-334867 Reduces Alcohol Relapse Drinking, but not Alcohol-Seeking, in Alcohol-Preferring (P) Rats.

Authors:  Ronnie Dhaher; Sheketha R Hauser; Bruk Getachew; Richard L Bell; William J McBride; David L McKinzie; Zachary A Rodd
Journal:  J Addict Med       Date:  2010-09       Impact factor: 3.702

2.  Disposition of d-penicillamine, a promising drug for preventing alcohol-relapse. Influence of dose, chronic alcohol consumption and age: studies in rats.

Authors:  Alejandro Orrico; Lucía Martí-Prats; M José Cano-Cebrián; Ana Polache; Teodoro Zornoza; Luis Granero
Journal:  Biopharm Drug Dispos       Date:  2014-04-06       Impact factor: 1.627

3.  Effects of naltrexone alone and in combination with acamprosate on the alcohol deprivation effect in rats.

Authors:  Charles J Heyser; Kelly Moc; George F Koob
Journal:  Neuropsychopharmacology       Date:  2003-04-09       Impact factor: 7.853

4.  The metabotropic glutamate 2/3 receptor agonist LY404039 reduces alcohol-seeking but not alcohol self-administration in alcohol-preferring (P) rats.

Authors:  Zachary A Rodd; David L McKinzie; Richard L Bell; Victoria K McQueen; James M Murphy; Darryle D Schoepp; William J McBride
Journal:  Behav Brain Res       Date:  2006-05-06       Impact factor: 3.332

5.  Time course of acamprosate action on operant ethanol self-administration after ethanol deprivation.

Authors:  S M Hölter; R Landgraf; W Zieglgänsberger; R Spanagel
Journal:  Alcohol Clin Exp Res       Date:  1997-08       Impact factor: 3.455

6.  Conjugation of acetaldehyde with cysteinylglycine, the first metabolite in glutathione breakdown by gamma-glutamyltranspeptidase.

Authors:  Y Kera; T Kiriyama; S Komura
Journal:  Agents Actions       Date:  1985-10

Review 7.  Animal models for medications development targeting alcohol abuse using selectively bred rat lines: neurobiological and pharmacological validity.

Authors:  Richard L Bell; Helen J K Sable; Giancarlo Colombo; Petri Hyytia; Zachary A Rodd; Lawrence Lumeng
Journal:  Pharmacol Biochem Behav       Date:  2012-07-25       Impact factor: 3.533

8.  Key role of ethanol-derived acetaldehyde in the motivational properties induced by intragastric ethanol: a conditioned place preference study in the rat.

Authors:  Alessandra T Peana; Paolo Enrico; Anna Rita Assaretti; Elena Pulighe; Giulia Muggironi; Maria Nieddu; Antonio Piga; Alessandra Lintas; Marco Diana
Journal:  Alcohol Clin Exp Res       Date:  2007-12-21       Impact factor: 3.455

Review 9.  Ethanol and acetaldehyde action on central dopamine systems: mechanisms, modulation, and relationship to stress.

Authors:  Miriam Melis; Marco Diana; Paolo Enrico; Michela Marinelli; Mark S Brodie
Journal:  Alcohol       Date:  2009-11       Impact factor: 2.405

10.  Ethanol-derived acetaldehyde: pleasure and pain of alcohol mechanism of action.

Authors:  Giulia Muggironi; Giulia R Fois; Marco Diana
Journal:  Front Behav Neurosci       Date:  2013-07-17       Impact factor: 3.558

View more
  4 in total

1.  Effects of Cocaine Exposure on Astrocytic Glutamate Transporters and Relapse-Like Ethanol-Drinking Behavior in Male Alcohol-Preferring Rats.

Authors:  Alaa M Hammad; Youssef Sari
Journal:  Alcohol Alcohol       Date:  2020-04-16       Impact factor: 2.826

Review 2.  From Ethanol to Salsolinol: Role of Ethanol Metabolites in the Effects of Ethanol.

Authors:  Alessandra T Peana; Michela Rosas; Simona Porru; Elio Acquas
Journal:  J Exp Neurosci       Date:  2016-11-20

Review 3.  Pre-Clinical Studies with D-Penicillamine as a Novel Pharmacological Strategy to Treat Alcoholism: Updated Evidences.

Authors:  Alejandro Orrico; Lucía Martí-Prats; María J Cano-Cebrián; Luis Granero; Ana Polache; Teodoro Zornoza
Journal:  Front Behav Neurosci       Date:  2017-03-07       Impact factor: 3.558

4.  The Role of Acetaldehyde in the Increased Acceptance of Ethanol after Prenatal Ethanol Exposure.

Authors:  Mirari Gaztañaga; Asier Angulo-Alcalde; Norman E Spear; M Gabriela Chotro
Journal:  Front Behav Neurosci       Date:  2017-01-31       Impact factor: 3.558

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.